# LEAD CANDIDATE IDENTIFICATION PK AND TOXICOLOGY STUDIES FOR ANTIBODY PROJECT IN BLUEPRINT NEUROTHERAPEUTICS (BPN) BIOLOGICS PROGRAM

> **NIH NIH N01** · ADVANCED BIOSCIENCE LABORATORIES, INC. · 2024 · $497,895

## Abstract

The National Institute of Neurological Disorders and Stroke (NINDS), via its Blueprint 
Neurotherapeutics (BPN) Biologics Program, is funding a pharmacokinetic and non-GLP 
toxicology studies and manufacturing a monoclonal antibody for Duchenne Muscular Dystrophy. These studies will support IND-enabling 
studies and a subsequent Investigational New Drug (IND) filing.

## Key facts

- **NIH application ID:** 11212628
- **Project number:** 75N95022D00023-0-759502400003-1
- **Recipient organization:** ADVANCED BIOSCIENCE LABORATORIES, INC.
- **Principal Investigator:** KUMAR REDDY
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $497,895
- **Award type:** —
- **Project period:** 2024-07-19 → 2026-07-18

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11212628

## Citation

> US National Institutes of Health, RePORTER application 11212628, LEAD CANDIDATE IDENTIFICATION PK AND TOXICOLOGY STUDIES FOR ANTIBODY PROJECT IN BLUEPRINT NEUROTHERAPEUTICS (BPN) BIOLOGICS PROGRAM (75N95022D00023-0-759502400003-1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/11212628. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*